Cargando…
Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis
Objective. The aim of our study was to investigate the frequency and pattern of cognitive impairment in patients with clinically isolated syndromes and definite diagnosis of multiple sclerosis within the last 2 years. Methods. We assessed the cognitive status of 46 patients aged 18–49 years with cli...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402565/ https://www.ncbi.nlm.nih.gov/pubmed/25944978 http://dx.doi.org/10.1155/2014/637694 |
_version_ | 1782367278263697408 |
---|---|
author | Baysal Kıraç, Leyla Ekmekçi, Özgül Yüceyar, Nur Sağduyu Kocaman, Ayşe |
author_facet | Baysal Kıraç, Leyla Ekmekçi, Özgül Yüceyar, Nur Sağduyu Kocaman, Ayşe |
author_sort | Baysal Kıraç, Leyla |
collection | PubMed |
description | Objective. The aim of our study was to investigate the frequency and pattern of cognitive impairment in patients with clinically isolated syndromes and definite diagnosis of multiple sclerosis within the last 2 years. Methods. We assessed the cognitive status of 46 patients aged 18–49 years with clinically isolated syndromes or definite diagnosis of multiple sclerosis who have onset of their symptoms within the last 2 years. Patients were matched with 40 healthy participants for age, sex, and educational level. Neuropsychological assessment was performed by stroop test, paced auditory serial addition test (PASAT), controlled oral word association test (COWAT), clock drawing test, trail making test (TMT), faces symbol test (FST). Hamilton Depression Scale and Modified Fatigue Impact Scale were used to quantify the severity of any depression and fatigue the subjects might suffer. Results. 19.6% of early MS/CIS group failed at 4 and more tests and had significant cognitive impairment focused on attention, executive functions, memory, and learning. No significant relationship was found between cognitive impairment and disability and fatigue scores. Discussion. Cognitive impairment can be present from the earliest stage of multiple sclerosis. It should be considered among the main manifestations of MS even in the earliest stages of the disease. |
format | Online Article Text |
id | pubmed-4402565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-44025652015-05-05 Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis Baysal Kıraç, Leyla Ekmekçi, Özgül Yüceyar, Nur Sağduyu Kocaman, Ayşe Behav Neurol Research Article Objective. The aim of our study was to investigate the frequency and pattern of cognitive impairment in patients with clinically isolated syndromes and definite diagnosis of multiple sclerosis within the last 2 years. Methods. We assessed the cognitive status of 46 patients aged 18–49 years with clinically isolated syndromes or definite diagnosis of multiple sclerosis who have onset of their symptoms within the last 2 years. Patients were matched with 40 healthy participants for age, sex, and educational level. Neuropsychological assessment was performed by stroop test, paced auditory serial addition test (PASAT), controlled oral word association test (COWAT), clock drawing test, trail making test (TMT), faces symbol test (FST). Hamilton Depression Scale and Modified Fatigue Impact Scale were used to quantify the severity of any depression and fatigue the subjects might suffer. Results. 19.6% of early MS/CIS group failed at 4 and more tests and had significant cognitive impairment focused on attention, executive functions, memory, and learning. No significant relationship was found between cognitive impairment and disability and fatigue scores. Discussion. Cognitive impairment can be present from the earliest stage of multiple sclerosis. It should be considered among the main manifestations of MS even in the earliest stages of the disease. Hindawi Publishing Corporation 2014 2014-04-14 /pmc/articles/PMC4402565/ /pubmed/25944978 http://dx.doi.org/10.1155/2014/637694 Text en Copyright © 2014 Leyla Baysal Kıraç et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Baysal Kıraç, Leyla Ekmekçi, Özgül Yüceyar, Nur Sağduyu Kocaman, Ayşe Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis |
title | Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis |
title_full | Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis |
title_fullStr | Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis |
title_full_unstemmed | Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis |
title_short | Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis |
title_sort | assessment of early cognitive impairment in patients with clinically isolated syndromes and multiple sclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402565/ https://www.ncbi.nlm.nih.gov/pubmed/25944978 http://dx.doi.org/10.1155/2014/637694 |
work_keys_str_mv | AT baysalkıracleyla assessmentofearlycognitiveimpairmentinpatientswithclinicallyisolatedsyndromesandmultiplesclerosis AT ekmekciozgul assessmentofearlycognitiveimpairmentinpatientswithclinicallyisolatedsyndromesandmultiplesclerosis AT yuceyarnur assessmentofearlycognitiveimpairmentinpatientswithclinicallyisolatedsyndromesandmultiplesclerosis AT sagduyukocamanayse assessmentofearlycognitiveimpairmentinpatientswithclinicallyisolatedsyndromesandmultiplesclerosis |